Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Abandoned drugs
CMV423
Другие языки:

    CMV423

    Подписчиков: 0, рейтинг: 0
    CMV423
    CMV423.svg
    Clinical data
    Other names CMV-423; RPR-111423
    Legal status
    Legal status
    • Investigational
    Identifiers
    • 2-Chloro-3-(pyridin-3-yl)-5,6,7,8-tetrahydroindolizine-1-carboxamide
    CAS Number
    PubChem CID
    ChemSpider
    UNII
    CompTox Dashboard (EPA)
    Chemical and physical data
    Formula C14H14ClN3O
    Molar mass 275.74 g·mol−1
    3D model (JSmol)
    • c1cc(cnc1)c2c(c(c3n2CCCC3)C(=O)N)Cl
    • InChI=1S/C14H14ClN3O/c15-12-11(14(16)19)10-5-1-2-7-18(10)13(12)9-4-3-6-17-8-9/h3-4,6,8H,1-2,5,7H2,(H2,16,19)
    • Key:KNGXENHWYNLKBU-UHFFFAOYSA-N

    CMV423 (2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide) is an experimental antiviral drug that has been studied for the treatment of cytomegalovirus (CMV) infection and human herpesvirus 6 (HHV-6) infection. The drug was investigated by Sanofi-Aventis, but its development was discontinued by 2018 before entering clinical trials.


    Новое сообщение